Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Kokkinakis

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Pharmacology|January 27, 2000
Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines. Effect of metabolismD M Kokkinakis, R C Moschel, A E Pegg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosoureaD M Kokkinakis, R C Moschel, A E Pegg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomideD M Kokkinakis, D B Bocangel, S C Schold, et al.
Cancer Research|February 1, 1985
Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450D M Kokkinakis, D R Koop, D G Scarpelli, et al.
Chemical Research in Toxicology|November 1, 1994
Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley ratsD M Kokkinakis, R C Moschel, A E Pegg, et al.
Journal of Neuropathology and Experimental Neurology|November 24, 1998
Glial tumors in the MNU rat model: induction of pure and mixed gliomas that do not require typical missense mutations of p53E J Rushing, M L Watson, S C Schold, et al.
Cancer Research|May 1, 1996
Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNUS C Schold, D M Kokkinakis, J L Rudy, et al.
Cancer Research|December 11, 1997
Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agentsD M Kokkinakis, M M Ahmed, R Delgado, et al.
British Journal of Cancer|January 1, 1997
Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cellsD M Kokkinakis, M A von Wronski, T H Vuong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancerM H Wu, K E Lohrbach, O I Olopade, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 27, 2000
Potentiation of BCNU antitumor efficacy by 9-substituted O6-benzylguanines. Effect of metabolismD M Kokkinakis, R C Moschel, A E Pegg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosoureaD M Kokkinakis, R C Moschel, A E Pegg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomideD M Kokkinakis, D B Bocangel, S C Schold, et al.
Cancer Research|February 1, 1985
Metabolism of N-nitroso-2,6-dimethylmorpholine by isozymes of rabbit liver microsomal cytochrome P-450D M Kokkinakis, D R Koop, D G Scarpelli, et al.
Chemical Research in Toxicology|November 1, 1994
Metabolism and disposition of O6-benzyl-2'-deoxyguanosine in Sprague-Dawley ratsD M Kokkinakis, R C Moschel, A E Pegg, et al.
Journal of Neuropathology and Experimental Neurology|November 24, 1998
Glial tumors in the MNU rat model: induction of pure and mixed gliomas that do not require typical missense mutations of p53E J Rushing, M L Watson, S C Schold, et al.
Cancer Research|May 1, 1996
Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNUS C Schold, D M Kokkinakis, J L Rudy, et al.
Cancer Research|December 11, 1997
Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agentsD M Kokkinakis, M M Ahmed, R Delgado, et al.
British Journal of Cancer|January 1, 1997
Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cellsD M Kokkinakis, M A von Wronski, T H Vuong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Lack of evidence for a polymorphism at codon 160 of human O6-alkylguanine-DNA alkyltransferase gene in normal tissue and cancerM H Wu, K E Lohrbach, O I Olopade, et al.
Pageof 4